These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26107063)

  • 21. [The first vaccine for prevention of cervix cancer and other human papillomavirus related diseases gets a positive evaluation by the European Drug Authority].
    Kinderkrankenschwester; 2006 Sep; 25(9):389-90. PubMed ID: 17017592
    [No Abstract]   [Full Text] [Related]  

  • 22. Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.
    Kind AB; Pavelyev A; Kothari S; El Mouaddin N; Schmidt A; Morais E; Guggisberg P; Lienert F
    BMC Public Health; 2020 May; 20(1):671. PubMed ID: 32398057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine.
    Di Mario S; Basevi V; Borsari S; Balduzzi S; Magrini N
    Lancet Oncol; 2012 Feb; 13(2):e50; author reply e50. PubMed ID: 22300857
    [No Abstract]   [Full Text] [Related]  

  • 24. [Vaccine against human papillomavirus. The Danish Society of Gynecology and Obstetrics].
    Kjaer SK
    Ugeskr Laeger; 2006 Mar; 168(12):1218. PubMed ID: 16571309
    [No Abstract]   [Full Text] [Related]  

  • 25. Search for HPV treatment vaccine heats up, researchers optimistic.
    McNeil C
    J Natl Cancer Inst; 2006 Jul; 98(14):954-5. PubMed ID: 16849674
    [No Abstract]   [Full Text] [Related]  

  • 26. HPV vaccine effect: is the glass half full or half empty?
    Saraiya M; Hariri S
    Lancet; 2011 Jun; 377(9783):2057-8. PubMed ID: 21684367
    [No Abstract]   [Full Text] [Related]  

  • 27. Human papillomavirus vaccine efficacy: aligning expectations with reality.
    Smith-McCune KK
    Gynecol Oncol; 2008 Oct; 111(1):1-2. PubMed ID: 18922296
    [No Abstract]   [Full Text] [Related]  

  • 28. Currently approved prophylactic HPV vaccines.
    Harper DM
    Expert Rev Vaccines; 2009 Dec; 8(12):1663-79. PubMed ID: 19943762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression from human papillomavirus (HPV) infection to cervical lesion or clearance in women (18-25 years): Natural history study in the control arm subjects of AS04-HPV-16/18 vaccine efficacy study in China between 2008 and 2016.
    Welby S; Rosillon D; Feng Y; Borys D
    Expert Rev Vaccines; 2022 Mar; 21(3):407-413. PubMed ID: 34939897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV vaccination for the prevention of cervical intraepithelial neoplasia.
    Kahn JA
    N Engl J Med; 2009 Jul; 361(3):271-8. PubMed ID: 19605832
    [No Abstract]   [Full Text] [Related]  

  • 31. [In defence of women against HPV-infection].
    Blázovics A
    Orv Hetil; 2007 Apr; 148(17):813. PubMed ID: 17452313
    [No Abstract]   [Full Text] [Related]  

  • 32. [Well-founded role of HPV analysis in cervix cancer prevention].
    Johansson BC; Andersson S; Hjerpe A
    Lakartidningen; 2007 Feb 21-27; 104(8):608; author reply 608-9. PubMed ID: 17396462
    [No Abstract]   [Full Text] [Related]  

  • 33. Human papillomavirus as a target for management, prevention and therapy.
    Crosbie EJ; Kitchener HC
    Int J Hyperthermia; 2012; 28(6):478-88. PubMed ID: 22690976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles.
    Capri S; Gasparini R; Panatto D; Demarteau N
    Gynecol Oncol; 2011 Jun; 121(3):514-21. PubMed ID: 21334734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPV vaccination for the prevention of cervical cancer.
    Nurs Womens Health; 2010 Feb; 14(1):81-82. PubMed ID: 20137050
    [No Abstract]   [Full Text] [Related]  

  • 36. Fewer shots proposed to increase uptake of HPV vaccine.
    Dorans K
    Nat Med; 2010 Aug; 16(8):832-3. PubMed ID: 20689528
    [No Abstract]   [Full Text] [Related]  

  • 37. A human papillomavirus type 16 vaccine.
    Gambacorti CB
    N Engl J Med; 2003 Apr; 348(14):1402-5; author reply 1402-5. PubMed ID: 12678022
    [No Abstract]   [Full Text] [Related]  

  • 38. Monitoring HPV vaccination programmes.
    Canfell K
    BMJ; 2010 Mar; 340():c1666. PubMed ID: 20335330
    [No Abstract]   [Full Text] [Related]  

  • 39. Ladies first: should boys be vaccinated against HPV?
    Leon R
    Can Fam Physician; 2008 Jul; 54(7):967-8, 972-3. PubMed ID: 18625809
    [No Abstract]   [Full Text] [Related]  

  • 40. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up.
    Villa LL; Costa RL; Petta CA; Andrade RP; Paavonen J; Iversen OE; Olsson SE; Høye J; Steinwall M; Riis-Johannessen G; Andersson-Ellstrom A; Elfgren K; Krogh Gv; Lehtinen M; Malm C; Tamms GM; Giacoletti K; Lupinacci L; Railkar R; Taddeo FJ; Bryan J; Esser MT; Sings HL; Saah AJ; Barr E
    Br J Cancer; 2006 Dec; 95(11):1459-66. PubMed ID: 17117182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.